CancerNetwork Members: Login | Register
 
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
PATIENTS
NURSES
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

ONCOLOGY. Vol. 23 No. 14
Announcements 

CMS Releases 2010 Physician Fee Schedule

January 14, 2010

On October 30, the Centers for Medicare & Medicaid Services (CMS) released the final 2010 physician fee schedule that includes a 1% reduction for oncology services for 2010. Oncology will still be subject to a 6% total cut that will be phased in over 4 years. This is less drastic than the 6% cut for 2010 that CMS included in its proposed fee schedule. However, the American Society of Clinical Oncology (ASCO) stated that it is concerned about any cuts to oncology and will be working to mitigate those cuts in the coming months. ASCO sent out a Member Alert November 4, highlighting key components of the fee schedule that affect oncology practices.
Praise From ASTRO

The American Society for Radiation Oncology (ASTRO) praised CMS for limiting the payment reductions initially proposed for radiation oncology and spreading the remaining cuts over 4 years. ASTRO had asked CMS to not implement proposed changes to the Medicare policies and payment rates for physician services that would have cut radiation oncology services by 19%, with certain services being cut by up to 44%. An ASTRO survey conducted in July indicated cuts of this scale would have a particularly devastating effect on community-based cancer centers and the patients they treat. The final rule is slated to reduce radiation oncology payments by only 5% over a 4-year period, or only about a 1% cut for 2010.

“CMS’s important action will allow radiation oncologists, particularly those working in community-based practices, to continue providing lifesaving radiation treatments for cancer patients. Keeping these clinics open and continuing to see Medicare beneficiaries with cancer will ensure cancer patients have local access to their essential daily treatments,” ASTRO Chair Patricia Eifel, MD, FASTRO, a radiation oncologist at M.D. Anderson Cancer Center in Houston, said.

Criticism From COA
 The Community Oncology Alliance (COA) criticized the newest round of cuts in cancer care as a move in the wrong direction of health-care reform. Although not as devastating as expected, the cuts by CMS will still decrease reimbursements far beyond what the US cancer care delivery system, including most patients, can bear, according to COA.

“Oncologists have endured substantial Medicare payment reductions since 2004,” said Patrick Cobb, MD, president of COA and managing partner of Hematology-Oncology Center of the Northern Rockies in Billings, Montana. “Some practices will not survive even lower reimbursements again next year. This will limit the availability of care and the access to care, ultimately jeopardizing patient well-being. This most recent round of cuts is the first step to a slow death for cancer practices and to access problems for our patients.”
 

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





 
TOPIC INDEX

  • Bladder Cancer
  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GIST
  • Genetics Genomics
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Integrative Oncology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast
  • Testicular Cancer


More Topics 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Head and Neck Tumors
  • 46-Year-Old Woman Presents With Difficulty in Ambulation, and Swelling and Discoloration of Both Eyelids
  • Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches
  • A 28-Year-Old Woman Presents With a Long-Standing History of Intermittently Painful “Bumps” on Both Her Shoulders and Upper Back
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Evolution of Treatment Options for Patients With CRPC and Bone Metastases: Bone-Targeted Agents That Go Beyond Palliation of Symptoms to Improve Overall Survival
  • Ending the Shortage of Generic Oncology Drugs
  • Processed and Red Meat Consumption Linked to Slight Increase in Risk of Pancreatic Cancer
  • New Mutation May Act as Driver in Subset of Lung Cancer Patients
  • Could Aspirin Be a Viable Adjuvant Treatment for Cancer?
  • Advances and New Research in the Treatment of Kidney Cancer
  • New Way to Predict Prostate Cancer Severity—Size of Prostate
  • Vismodegib Granted FDA Approval for Treatment of Basal Cell Carcinoma
  • FDA Grants Approval to Axitinib for the Treatment of Advanced Renal Cell Carcinoma
  • Why BRAF-Mutated Colorectal Cancers Don't Respond to BRAF Inhibitors
Click here to subscribe to our newsletter
 
CME ACTIVITIES

Optimal Care for HER2+ Breast Cancer

An interactive case challenge activity.

 

The goal of this activity is to clarify challenging treatment issues of HER2+ breast cancer including incorporation of predictive and prognostic biomarker tests and evidence-based data into practice when determining individualized strategies that improve patient survival and quality of life.

 

 Go to Activity

 
CONNECT WITH US
Become a fan on
Facebook
Add us on
Google Plus
Follow us on
Twitter
Sign up for our
Newsletters
Subscribe to our
RSS Feed
CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy